Is the Sudan virus deadlier than Ebola? A key discovery explains how it clings to human cells. The Sudan virus, a close relative of Ebola, has a 50% fatality rate, but its mechanisms of cell ...

The Ugandan government and the World Health Organization recently confirmed an outbreak of Sudan virus disease. The index (first-known) case of this outbreak is thought to be a 32-year-old male nurse ...

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist.

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist. To address this ...

The Sudan virus belongs to the same family as the Ebola virus. The announcement came after the death of a 32-year-old male nurse in the capital, Kampala, who tested positive for the virus during a ...

The study comes amid an outbreak of the Sudan Ebola virus, which has already killed a nurse and infected others. A nurse administers the first injection of the Sudan Ebola vaccine to a volunteer ...

Most often, Ebola outbreaks have been caused by the Zaire type of the Ebola virus (Zaire ebolavirus) and the Sudan type (Sudan ebolavirus). During the most recent outbreaks, which have had high ...

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist. To address this critical ...

A clinical trial of a potentially effective vaccine against Sudan Virus Disease (SVD) has started in Uganda after the country’s Health Ministry confirmed a Sudan Ebola outbreak last week.

This is a critical achievement toward better pandemic preparedness and saving lives when outbreaks occur,” said Dr. Tedros ...

This will be the first trial to assess the clinical efficacy of a vaccine against Ebola disease due to the Sudan virus. In 2023, IAVI initiated a Phase I trial (NCT05724472) which determined the ...